THE CURRENT MANAGEMENT OF VASCULAR BIRTHMARKS

被引:192
作者
ENJOLRAS, O
MULLIKEN, JB
机构
[1] Interdisciplinary Study Group for Vascular Malformations, Department of Neuroradiology, Hôpital Lariboisière
[2] Craniofacial Center, Division of Plastic Surgery, Children's Hospital
[3] Department of Dermatology, Hôpital Tarnier, Paris
[4] Harvard Medical School, Boston, Massachusetts
关键词
D O I
10.1111/j.1525-1470.1993.tb00393.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Two vascular birthmarks are hemangiomas and vascular malformations. Hemangiomas grow by cellular proliferation. Their hallmark is rapid neonatal growth. Spontaneous regression begins when the infant is 6 to 1 0 months old, but it may continue until 8 to 1 0 years of age. Hemangiomas are infrequently life-threatening. Pharmacologic treatment is indispensible; unsightly sequelae require surgical treatment. Vascular malformations consist of dysplastic vessels and are present on a lifelong basis. They are either slow-flow (capillary, venous, lymphatic) or fast-flow anomalies with arteriovenous shunting. Complex combined vascular malformations are observed as well. Ten years ago angiographic studies clearly demonstrated the differences among the various lesions. Today a noninvasive diagnostic approach is recommended, particularly in children. Ultrasonography, Doppler flow imaging, and magnetic resonance imaging are the most informative techniques, revealing the extent of tissue involvement and differentiating fast-flow from slow-flow anomalies. Risks and management differ depending on the type of vascular malformation.
引用
收藏
页码:311 / 333
页数:23
相关论文
共 63 条
[21]  
Lemarchand-Venencie F, Enjolras O, Riche MC, Et al., Corticothérapie in situ dans les hémangiomes, Ann Dermatol Venereol, 116, pp. 806-807, (1989)
[22]  
Shorr N, Seiff SR, Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma, Ophthalmol Surg, 17, pp. 229-231, (1986)
[23]  
Wilson RS, McGrew RN, White HJ, Bilateral retinal artery and choriocapillaris occlusion following the injection of long‐acting corticosteroid suspensions in combination with other drugs
[24]  
animal experimental study, Ophthalmology, 85, pp. 975-985, (1978)
[25]  
Vasquez-Botet R, Reyes BA, Vasquez-Botet M, Sclerodermiform linear atrophy after the use of intralesional steroids for periorbital hemangiomas: a review of complications, J Pediatr Ophthalmol Strabismus, 26, pp. 124-127, (1989)
[26]  
Ezekowitz RAB, Mulliken JB, Folkman J, Interferon alfa‐2a therapy for life‐threatening hemangiomas, N Engl J Med, 326, pp. 1456-1463, (1992)
[27]  
De Prost Y, Teillac D, Bodemer C, Et al., Successful treatment of Kasabach‐Merritt syndrome with pentoxifylline, J Am Acad Dermatol, 25, pp. 854-855, (1991)
[28]  
Burrows PE, Lasjaunias PL, Terbrugge K, Et al., Urgent and emergent embolizations of lesions of the head and neck in children, Pediatrics, 80, pp. 386-394, (1987)
[29]  
Garden JM, Bakus AD, Pailer AS, Treatment of cutaneous hemangiomas by the flashlamp pulsed dye laser: prospective analysis, J Pediatr, 120, pp. 555-560, (1992)
[30]  
Mulliken JB, A plea for a biologic approach to hemangiomas of infancy, Arch Dermatol, 127, pp. 243-244, (1991)